The impact of new technologies on vaccine development.

作者: Michael D. Winther , Gordon Dougan

DOI: 10.1080/02648725.1984.10647793

关键词:

摘要: The ability to move genetic determinants between species using in vitro gene-manipulation techniques has opened up new approaches vaccine development. This rapidly grown into an exciting area of research both academic and industrial laboratories. There are numerous scientific challenges which require multidisciplinary teams solve problems creating immunogens. challenged our existing knowledge about protein structure conformation, microbial pathogenicity the immune system. Recombinant-DNA invaluable as tools analysis antigen production. surface micro-organisms can also be minutely explored with use synthetic peptides monoclonal antibodies. Nevertheless, these technologies do not allow us circumvent need for detailed understanding pathogens disease process. What is apparent from work carried out so far that there few easy answers development it realistic expect rapid solutions problems. As many potential targets constructing novel vaccines human animal diseases, helpful establish some priorities. a tendency look at effective simply direct producing them more economically or enhanced safety stability. advantage this approach considerable background will have already been establishing basis application recombinant DNA techniques. However, lead conflicts (often within same institute company) old technologies. could detriment still only partly developed may good enough yet compete cost efficacy. ambitious, eventually rewarding, attempt develop where none had existed before. vast untapped market, especially parasitic but much likely necessary. Indeed, most accurately referred basic rather than totally new, way off. Having directed towards specific organism options available strategy adopt. discussed review possible consider subunits, antigens live (attenuated heterologous) organisms vaccines.(ABSTRACT TRUNCATED AT 400 WORDS)

参考文章(108)
M Rosenberg, D Court, Regulatory Sequences Involved in the Promotion and Termination of RNA Transcription Annual Review of Genetics. ,vol. 13, pp. 319- 353 ,(1979) , 10.1146/ANNUREV.GE.13.120179.001535
A M Behbehani, The smallpox story: life and death of an old disease. Microbiological Research. ,vol. 47, pp. 455- 509 ,(1983) , 10.1128/MR.47.4.455-509.1983
P L Shipley, G Dougan, S Falkow, Identification and cloning of the genetic determinant that encodes for the K88ac adherence antigen. Journal of Bacteriology. ,vol. 145, pp. 920- 925 ,(1981) , 10.1128/JB.145.2.920-925.1981
R V van Eijk, H G van der Heide, J A de Jong, M F van Olderen, A B Osterhaus, L M Schouls, J D van Embden, H J van der Donk, Molecular cloning and expression of Treponema pallidum DNA in Escherichia coli K-12. Infection and Immunity. ,vol. 42, pp. 187- 196 ,(1983) , 10.1128/IAI.42.1.187-196.1983
P H Gilligan, J C Brown, D C Robertson, Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin Infection and Immunity. ,vol. 42, pp. 683- 691 ,(1983) , 10.1128/IAI.42.2.683-691.1983
F. Sanger, S. Nicklen, A. R. Coulson, DNA sequencing with chain-terminating inhibitors Proceedings of the National Academy of Sciences of the United States of America. ,vol. 74, pp. 5463- 5467 ,(1977) , 10.1073/PNAS.74.12.5463
S. van der Werf, C. Wychowski, P. Bruneau, B. Blondel, R. Crainic, F. Horodniceanu, M. Girard, Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 80, pp. 5080- 5084 ,(1983) , 10.1073/PNAS.80.16.5080
L A Chedid, M A Parant, F M Audibert, G J Riveau, F J Parant, E Lederer, J P Choay, P L Lefrancier, Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infection and Immunity. ,vol. 35, pp. 417- 424 ,(1982) , 10.1128/IAI.35.2.417-424.1982